Theranos was hit with a second class action lawsuit today — one day after an angry customer filed the first.
Today's suit alleges that Theranos breached its contract with customers by "providing tests that were not of the promised high level of accuracy and quality." The lawsuit also goes after Theranos for false advertising, not performing proper quality control, and for failing to use the fingerprick technologies that it advertised to customers when drawing their blood, according to the complaint.